Development of Extemporaneous Compounding as an Initiating Factor in the Transformation of Pharmaceutical Education: International Experience and Current Trends

INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to en...

Full description

Saved in:
Bibliographic Details
Published in:Regulatory Research and Medicine Evaluation Vol. 14; no. 4; pp. 419 - 436
Main Authors: Mandrik, M. A., Sadkovskii, I. A., Korol, L. A., Egorova, S. N., Krasnyuk, I. I., Bykov, A. V.
Format: Journal Article
Language:English
Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 01-09-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems. AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions. MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities. RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems. CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency.
AbstractList INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems. AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions. MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities. RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems. CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency.
INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems.AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions.MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities.RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems.CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency.
Author Bykov, A. V.
Korol, L. A.
Egorova, S. N.
Sadkovskii, I. A.
Mandrik, M. A.
Krasnyuk, I. I.
Author_xml – sequence: 1
  givenname: M. A.
  orcidid: 0000-0002-3558-9615
  surname: Mandrik
  fullname: Mandrik, M. A.
  organization: I.M. Sechenov First Moscow State Medical University (Sechenov University)
– sequence: 2
  givenname: I. A.
  orcidid: 0000-0001-8375-9909
  surname: Sadkovskii
  fullname: Sadkovskii, I. A.
  organization: I.M. Sechenov First Moscow State Medical University (Sechenov University)
– sequence: 3
  givenname: L. A.
  orcidid: 0000-0001-5919-1866
  surname: Korol
  fullname: Korol, L. A.
  organization: I.M. Sechenov First Moscow State Medical University (Sechenov University)
– sequence: 4
  givenname: S. N.
  orcidid: 0000-0001-7671-3179
  surname: Egorova
  fullname: Egorova, S. N.
  organization: Kazan State Medical University
– sequence: 5
  givenname: I. I.
  orcidid: 0000-0002-7242-2988
  surname: Krasnyuk
  fullname: Krasnyuk, I. I.
  organization: I.M. Sechenov First Moscow State Medical University (Sechenov University)
– sequence: 6
  givenname: A. V.
  surname: Bykov
  fullname: Bykov, A. V.
  organization: R-Pharm
BookMark eNo9kd1uVCEUhYmpibX2Hbjw9ih_5wfjjRmnOkmTejFekw1sWswMTOAcU9_GRy1nqs1OgLVX9gdkvSUXKSck5D1nHySbdP-Ra807obnuBBOq46pr1ZSSwytyKZlUnVS9vPh_ZoN4Q65rjZb1I58UH_Ul-fsVf-Mhn46YZpoD3T7OeDzlAgnzUukmN7EkH9M9hUoh0V2Kc4R5bdyAm3OhMdH5Aem-zdSQy7GZOa2sHw_QlMNljg4OdOsXd_Y-NciMJZ3FajyesERMDtsFnm6WUtbX7Nvq6zvyOsCh4vW__Yr8vNnuN9-727tvu82X285xrvtu5KjRS49q8iLACHxyvQ5ikMyK5oEaHB-BKWshSOthUtoOVrY-AxekvCK7Z67P8MucSjxC-WMyRHNu5HJvoLSPHNA4ba2SgTMlQuNZDWKUkw1TP7kJ-r6xPj-zXMm1FgwvPM7MOTyzhmfW8MwanuHKtGqqhSefAAjAlDc
Cites_doi 10.1093/ijpp/riac062
10.1080/15602210500282517
10.1016/j.ajpe.2023.100116
10.5688/ajpe8617
10.1016/j.ajpe.2023.100571
10.26442/00403660.2022.08.201805
10.47093/2713-069X.2021.2.1.12-20
10.1186/s40545-023-00520-9
10.3390/children10010147
10.3390/pharmacy8030117
10.1016/j.cptl.2019.12.016
10.5688/ajpe81464
10.18288/1994-5124-2018-2-04
10.5688/ajpe768146
10.1186/s40545-023-00618-0
10.1016/j.cptl.2019.11.013
10.33920/med-13-2006-02
10.19163/2307-9266-2023-11-2-161-172
10.1016/j.cptl.2023.06.012
10.29060/TAPS.2018-3-1/OA1048
10.1136/ejhpharm-2019-001891
10.1016/j.ajpe.2023.100117
10.19163/2307-9266-2023-11-3-176-192
10.15829/1728-8800-2022-3481
10.5688/ajpe7394
10.5688/ajpe8345
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.30895/1991-2919-2024-14-4-419-436
DatabaseName CrossRef
Open Access: DOAJ - Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 3034-3453
EndPage 436
ExternalDocumentID oai_doaj_org_article_c9bb43f1042f4bbb9a2738bf858c8a55
10_30895_1991_2919_2024_14_4_419_436
GroupedDBID AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
GROUPED_DOAJ
ID FETCH-LOGICAL-c1195-71e9ed3de48d2fa7a18c59f2630b21e9a46c17a04bbaf3bda849b6b3a460acf33
IEDL.DBID DOA
ISSN 3034-3062
IngestDate Mon Nov 11 19:40:06 EST 2024
Fri Nov 22 01:29:53 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4
Language English
Russian
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1195-71e9ed3de48d2fa7a18c59f2630b21e9a46c17a04bbaf3bda849b6b3a460acf33
ORCID 0000-0002-3558-9615
0000-0001-5919-1866
0000-0002-7242-2988
0000-0001-8375-9909
0000-0001-7671-3179
OpenAccessLink https://doaj.org/article/c9bb43f1042f4bbb9a2738bf858c8a55
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_c9bb43f1042f4bbb9a2738bf858c8a55
crossref_primary_10_30895_1991_2919_2024_14_4_419_436
PublicationCentury 2000
PublicationDate 2024-09-01
PublicationDateYYYYMMDD 2024-09-01
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-01
  day: 01
PublicationDecade 2020
PublicationTitle Regulatory Research and Medicine Evaluation
PublicationYear 2024
Publisher Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
Publisher_xml – name: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
References ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref27
  doi: 10.1093/ijpp/riac062
– ident: ref1
– ident: ref15
  doi: 10.1080/15602210500282517
– ident: ref7
– ident: ref29
  doi: 10.1016/j.ajpe.2023.100116
– ident: ref25
– ident: ref31
  doi: 10.5688/ajpe8617
– ident: ref28
  doi: 10.1016/j.ajpe.2023.100571
– ident: ref2
  doi: 10.26442/00403660.2022.08.201805
– ident: ref8
  doi: 10.47093/2713-069X.2021.2.1.12-20
– ident: ref14
  doi: 10.1186/s40545-023-00520-9
– ident: ref13
  doi: 10.3390/children10010147
– ident: ref11
– ident: ref17
  doi: 10.3390/pharmacy8030117
– ident: ref6
– ident: ref22
  doi: 10.1016/j.cptl.2019.12.016
– ident: ref24
  doi: 10.5688/ajpe81464
– ident: ref4
  doi: 10.18288/1994-5124-2018-2-04
– ident: ref19
  doi: 10.5688/ajpe768146
– ident: ref32
  doi: 10.1186/s40545-023-00618-0
– ident: ref21
– ident: ref23
  doi: 10.1016/j.cptl.2019.11.013
– ident: ref10
  doi: 10.33920/med-13-2006-02
– ident: ref5
  doi: 10.19163/2307-9266-2023-11-2-161-172
– ident: ref33
  doi: 10.1016/j.cptl.2023.06.012
– ident: ref18
  doi: 10.29060/TAPS.2018-3-1/OA1048
– ident: ref20
  doi: 10.1136/ejhpharm-2019-001891
– ident: ref12
  doi: 10.1016/j.ajpe.2023.100117
– ident: ref3
  doi: 10.19163/2307-9266-2023-11-3-176-192
– ident: ref9
  doi: 10.15829/1728-8800-2022-3481
– ident: ref16
– ident: ref26
  doi: 10.5688/ajpe7394
– ident: ref30
  doi: 10.5688/ajpe8345
SSID ssib057184179
ssib056345391
ssib057142307
Score 1.9336404
Snippet INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical...
SourceID doaj
crossref
SourceType Open Website
Aggregation Database
StartPage 419
SubjectTerms accreditation
compounding pharmacies
extemporaneous compounding
international experience
licensing of pharmaceutical workers
pharmaceutical education
pharmacy technician
Title Development of Extemporaneous Compounding as an Initiating Factor in the Transformation of Pharmaceutical Education: International Experience and Current Trends
URI https://doaj.org/article/c9bb43f1042f4bbb9a2738bf858c8a55
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgB8QFFZWKQovm0KvVxN_m1pZdlQuqRJF6i_wpuGRRy0r8HH4qM07YDScuKCcnSiL7vcgz9ssbxs5llKHEbHjxRnFVUuRR-sxtVdLpVJNqYsybz_bTvfuwIpucXakv0oRN9sDTwF0kH6OSFbMGUVWM0Qf6mSRWp11yQU_upZ1ZJFPIJG2k0nLvAqNtr8TC-ArbjkpvUQmzTtLWgBHP2DmlsJ3z-qLpgYTvPZJIKN5jL2i7lKvm5LyfvxY2_20-Wh-yF3MgCZdTB16yJw_bI_ZroQGCTYXVz9l6aiyY4QN9_FRGCacrCI8QRvhI2qFA0mdYt8o78G0EjAnhbhHQbkZ61u3X5eo37JQh7-GvVUXYmyfjCzLMBlAwiW9fsS_r1d31DZ9rMPBEZnDc9sWXLHNRLosabOhd0r4KI7so8FpQJvU2dAhNqDLm4JSPBgmgTBdSlfKYHYybsbxmYFLGeCLbVASmJcJGn6StpTalVbT9CdN_Rnb4PlltDJiiNEQGQmQgRAZCBBOWAQ9sISIn7Ipg2N1DhtntBNJomGk0_ItGb_7HQ96y540vTYJ2yg5-PGzLGXv6mLfvGj1_A8jc5ho
link.rule.ids 315,782,786,866,2106,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Extemporaneous+Compounding+as+an+Initiating+Factor+in+the+Transformation+of+Pharmaceutical+Education%3A+International+Experience+and+Current+Trends&rft.jtitle=Regulatory+Research+and+Medicine+Evaluation&rft.au=Mandrik%2C+M.+A.&rft.au=Sadkovskii%2C+I.+A.&rft.au=Korol%2C+L.+A.&rft.au=Egorova%2C+S.+N.&rft.date=2024-09-01&rft.issn=3034-3062&rft.eissn=3034-3453&rft.volume=14&rft.issue=4&rft.spage=419&rft.epage=436&rft_id=info:doi/10.30895%2F1991-2919-2024-14-4-419-436&rft.externalDBID=n%2Fa&rft.externalDocID=10_30895_1991_2919_2024_14_4_419_436
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=3034-3062&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=3034-3062&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=3034-3062&client=summon